Status:
UNKNOWN
Colon Cancer Prevention Using Selenium
Lead Sponsor:
University of Illinois at Chicago
Conditions:
Prevention of Colorectal Cancer
Eligibility:
All Genders
50+ years
Phase:
EARLY_PHASE1
Brief Summary
Selenium's ability to prevent colorectal cancer (CRC) has been suspected for nearly 30 years, but has never been directly studied in humans. The investigators will directly assess selenium's ability t...
Eligibility Criteria
Inclusion
- \- All non-pregnant patients \>50 years of age
Exclusion
- The following will be specifically looked for, and result in patients not being eligible for study enrollment:
- Use of non-steroidal anti-inflammatory drugs or glucocorticosteroids within 60 days of study entry.
- History of chronic IBD or prior pelvic radiation (inflammation distorts crypt pattern).
- Intake of any selenium supplements within 60 days of study entry, including vitamins.
- Patients with increased bleeding risk from biopsy protocol (i.e. renal failure, decompensated cirrhosis, blood dyscrasia).
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01211561
Start Date
December 1 2010
End Date
December 1 2016
Last Update
September 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago Medical Center
Chicago, Illinois, United States, 60612